Harmonization, Patient Trust Among Challenges In Regulating AI Devices
A panel of regulators and industry experts offered a variety of perspectives on artificial intelligence in medical devices and other digital health technology during the MedTech Conference in Boston.
You may also be interested in...
Medtech Insight spoke to MedCrypt director Naomi Schwartz about how proactive cybersecurity can ease premarket burdens for diabetes care manufacturers.
The pace of artificial intelligence development has accelerated in recent years and now most of the artificial intelligence devices approved by the FDA are imaging devices.
RQM’s Allison Komiyama and Kevin Go summarized up the year’s changes to digital health regulation and outlined what to expect in the coming year.